Letter Of Invitation
The Diabetes Technology Society (DTS) invites researchers, physicians, and health care professionals from around the world to attend the 13th Annual Diabetes Technology Meeting on October 31 to November 2, 2013 at the Hyatt Regency San Francisco Airport in Burlingame, California.
This will be an excellent opportunity to meet leading scientists in the field of diabetes research and learn about the latest technological advances for people with diabetes. Last year’s meeting in Bethesda, Maryland, brought together over 500 clinicians and scientists from 24 countries to focus on applying science and technology to fight diabetes.
This year’s Diabetes Technology Meeting will include sessions on: (1) mHealth; (2) Using Continuous Glucose Monitoring to Assess Metabolic Flexibility, Glucose Complexity and Glycemic Variability; (3) Artificial Pancreas: Technology; (4) Artificial Pancreas: Outcomes; (5) New Insulin and Delivery Systems; (6) Tissue Reactions to Implanted CGM Sensors; (7) Novel Hypoglycemia Alarms; and (8) Future Directions in Diabetes Apps, as well as live demonstrations. As an added feature, the presentations will also incorporate an audience response system.
The format will include state-of-the-art lectures, oral presentations of abstracts, panel discussions with Q&A sessions, and two poster sessions. A syllabus of the submitted abstracts will be distributed to all attendees. Last year we received over 160 abstracts.
On Thursday, October 31, Diabetes Technology Society will present 4 optional pre-meeting workshops.
Concurrent morning workshops are:
- Workshop A: Establishing and Maintaining High Standards for Blood Glucose Monitoring
- Workshop B: Using Self-Monitoring Blood Glucose and Continuous Glucose Monitoring to Improve Outcomes
Concurrent afternoon sessions are:
- Workshop C: Generic Blood Glucose Monitors and Generic Strips
- Workshop D: Managing Patients Using New Pump and Insulin Delivery Technologies
On each afternoon of October 31–November 1, we will have a poster session from 4:00 pm to 6:30 pm. During the conference proper, November 1–2, breakfast and lunch will be provided, as well as morning and afternoon snacks.
Foreign nationals from particular countries must obtain a travel visa (B‐1) in order to attend this meeting. Visa applications are processed through the U.S. Embassy or Consulate of your country of citizenship. Detailed instructions on how to obtain a visa can be found on‐line at the U.S. Department of State Business Visa Center and the National Academies’ International Visitors Office. To assist foreign visitors in obtaining a visa, we have registered this conference with the U.S. Department of State. You will need a copy of this letter, along with copies of the meeting registration and hotel reservation confirmation to facilitate the visa application and approval process. You can register for the conference and hotel room through our website at: http://diabetestechnology.org/dtm.shtml. In addition to obtaining a travel visa, all foreign attendees are fully responsible for the costs of meeting registration, travel, lodging, and related expenses associated with attending this meeting.
We look forward to seeing you in San Francisco and sharing information about projects of mutual interest.
David C. Klonoff, M.D., FACP, Fellow AIMBE
Chair, Diabetes Technology Meeting Planning Committee